株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

掻痒治療薬の世界市場の予測

Global Pruritus Therapeutics Market Research Report 2017

発行 QYResearch 商品コード 597664
出版日 ページ情報 英文 124 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.62円で換算しております。
Back to Top
掻痒治療薬の世界市場の予測 Global Pruritus Therapeutics Market Research Report 2017
出版日: 2017年12月27日 ページ情報: 英文 124 Pages
概要

当レポートでは、世界の掻痒治療薬の市場を調査し、市場および製品の定義と概要、タイプ・用途・地域/主要国別の収益規模の推移と予測、市場への各種影響因子の分析、競合環境と市場シェア、主要製造業者のプロファイルなどをまとめています。

第1章 市場概要

  • 製品の概要・範囲
  • 市場分析・予測:タイプ別
    • 収益・成長率の比較
    • 市場シェア
    • コルチコステロイド
    • 抗ヒスタミン薬
    • カルシニューリン阻害剤
  • 市場分析・予測:用途別
    • 収益の比較
    • 外用薬
    • 経口薬
    • 注射剤
  • 市場分析・予測:地域別
  • 市場予測

第2章 競合分析:製造業者別

  • 収益・シェアの推移
  • 総利益・市場シェアの推移
  • 主要製造業者の本社・設立年
  • 競合状況・動向

第3章 収益の推移:地域別

第4章 収益の推移:タイプ別

第5章 収益の推移:用途別

第6章 主要製造業者の分析

  • J&J
  • Abbott
  • Amgen
  • LEO Pharma
  • Novartis
  • Bayer
  • Pfizer
  • UCB Pharma
  • GlaxoSmithKline
  • Galderma
  • Huapont

第7章 製造コストの分析

  • R&Dコストの分析
  • コスト構造の分析
  • 製造プロセスの分析

第8章 産業チェーン・調達戦略・下流バイヤー

第9章 マーケティング戦略・流通販売業者

第10章 市場影響因子の分析

  • 成長推進因子
  • 消費者のニーズと顧客の好みの変化
  • 政治経済環境の変化

第11章 市場予測

  • 収益予測
  • 収益予測:地域別
  • 収益予測:タイプ別
  • 収益予測:用途別

第12章 調査結果・総論

第13章 調査手法・データソース

目次

In the last several years, global market of Pruritus Therapeutics developed smoothly, with an average growth rate of 4.8%. In 2016, global consumption value of Pruritus Therapeutics is nearly 10.8 billion USD.

This report studies Pruritus Therapeutics in Global market, especially in North America, Europe, China, Rest of Asia, focuses on top manufacturers in global market, with revenue and market share for each manufacturer, covering:

  • J&J
  • Abbott
  • Amgen
  • LEO Pharma
  • Novartis
  • Bayer
  • Pfizer
  • UCB Pharma
  • GlaxoSmithKline
  • Galderma
  • Huapont

Market Segment by Regions, this report splits Global into several key Regions, with revenue, market share and growth rate of Pruritus Therapeutics in these regions, from 2012 to 2022 (forecast), like:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

Split by Product Types, with revenue market share and growth rate of each type, can be divided into:

  • Antihistamines
  • Corticosteroids
  • Calcineurin Inhibitors
  • Other

Split by applications, this report focuses on revenue market share and growth rate of Pruritus Therapeutics in each application, can be divided into:

  • External Use
  • Oral
  • Injection

Table of Contents

1. Pruritus Therapeutics Market Overview

  • 1.1. Product Overview and Scope of Pruritus Therapeutics
  • 1.2. Pruritus Therapeutics Segment by Types and Drugs Types
    • 1.2.1. Global Pruritus Therapeutics Revenue and Growth (%) Comparison by Types (2012-2022)
    • 1.2.2. Global Pruritus Therapeutics Revenue Market Share (%) by Types in 2016
    • 1.2.3. Corticosteroids
    • 1.2.4. Antihistamines
    • 1.2.5. Calcineurin Inhibitors
  • 1.3. Pruritus Therapeutics Segment by Applications
    • 1.3.1. Global Pruritus Therapeutics Revenue Comparison by Applications (2012-2022)
    • 1.3.2. External Use
    • 1.3.3. Oral
    • 1.3.4. Injection
  • 1.4. Pruritus Therapeutics Market by Regions
    • 1.4.1. Global Pruritus Therapeutics Market Size and Growth (%) Comparison by Regions
    • 1.4.2. North America Status and Prospect (2012-2022)
    • 1.4.3. Asia-Pacific Status and Prospect (2012-2022)
    • 1.4.4. Europe Status and Prospect (2012-2022)
    • 1.4.5. South America Status and Prospect (2012-2022)
    • 1.4.6. Middle East and Africa Status and Prospect (2012-2022)
  • 1.5. Global Market Size (Value) of Pruritus Therapeutics (2012-2022)

2. Global Pruritus Therapeutics Market Competition by Manufacturers

  • 2.1. Global Pruritus Therapeutics Revenue and Share by Manufacturers (2016 and 2017)
  • 2.2. Global Pruritus Therapeutics Gross Profit and Share by Manufacturers (2016 and 2017)
  • 2.3. Global Pruritus Therapeutics Gross Margin of Manufacturers (2016 and 2017)
  • 2.4. Manufacturers Pruritus Therapeutics Headquarters, Founded Time
  • 2.5. Pruritus Therapeutics Market Competitive Situation and Trends
    • 2.5.1. Pruritus Therapeutics Market Concentration Rate
    • 2.5.2. Pruritus Therapeutics Market Share of Top 3 and Top 5 Manufacturers
    • 2.5.3. Mergers. Acquisitions, Expansion

3. Global Pruritus Therapeutics Revenue (Value) by Regions (2012-2017)

  • 3.1. Global Pruritus Therapeutics Revenue (Value) and Market Share by Regions (2012-2017)
  • 3.2. Global Pruritus Therapeutics Gross Profit and Market Share by Regions (2012-2017)
  • 3.3. Global Pruritus Therapeutics Revenue and Gross Margin (2012-2017)
  • 3.4. North America Pruritus Therapeutics Revenue and Gross Margin (2012-2017)
  • 3.5. Europe Pruritus Therapeutics Revenue and Gross Margin (2012-2017)
  • 3.6. Asia-Pacific Pruritus Therapeutics Revenue and Gross Margin (2012-2017)
  • 3.7. South America Pruritus Therapeutics Revenue and Gross Margin (2012-2017)
  • 3.8. Middle East and Africa Pruritus Therapeutics Revenue and Gross Margin (2012-2017)

4. Global Pruritus Therapeutics Revenue Trend by Type

  • 4.1. Global Pruritus Therapeutics Revenue and Market Share by Product Catalog (2012-2017)
  • 4.2. Global Pruritus Therapeutics Revenue Growth by Type (2012-2017)

5. Global Pruritus Therapeutics Market Analysis by Applications

  • 5.1. Global Pruritus Therapeutics Revenue and Market Share by Applications (2012-2017)
  • 5.2. Global Pruritus Therapeutics Revenue Growth Rate (%) by Applications (2012-2017)

6. Analysis of Pruritus Therapeutics Industry Key Manufacturers

  • 6.1. J&J
    • 6.1.1. Company Profile
    • 6.1.2. Product Information
    • 6.1.3. Revenue, Gross Profit and Gross Margin
  • 6.2. Abbott
    • 6.2.1. Company Profile
    • 6.2.2. Product Information
    • 6.2.3. Revenue, Gross Profit and Gross Margin
  • 6.3. Amgen
    • 6.3.1. Company Profile
    • 6.3.2. Product Information
    • 6.3.3. Revenue, Gross Profit and Gross Margin
  • 6.4. LEO Pharma
    • 6.4.1. Company Profile
    • 6.4.2. Product Information
    • 6.4.3. Revenue, Gross Profit and Gross Margin
  • 6.5. Novartis
    • 6.5.1. Company Profile
    • 6.5.2. Product Information
    • 6.5.3. Revenue, Gross Profit and Gross Margin
  • 6.6. Bayer
    • 6.6.1. Company Profile
    • 6.6.2. Product Information
    • 6.6.3. Revenue, Gross Profit and Gross Margin
  • 6.7. Pfizer
    • 6.7.1. Company Profile
    • 6.7.2. Product Information
    • 6.7.3. Revenue, Gross Profit and Gross Margin
  • 6.8. UCB Pharma
    • 6.8.1. Company Profile
    • 6.8.2. Product Information
    • 6.8.3. Revenue, Gross Profit and Gross Margin
  • 6.9. GlaxoSmithKline
    • 6.9.1. Company Profile
    • 6.9.2. Product Information
    • 6.9.3. Revenue, Gross Profit and Gross Margin
  • 6.10. Galderma
    • 6.10.1. Company Profile
    • 6.10.2. Product Information
    • 6.10.3. Revenue, Gross Profit and Gross Margin
  • 6.11. Huapont
    • 6.11.1. Company Profile
    • 6.11.2. Product Information
    • 6.11.3. Revenue, Gross Profit and Gross Margin

7. Pruritus Therapeutics Manufacturing Cost Analysis

  • 7.1. Pruritus Therapeutics R&D Cost Analysis
    • 7.1.1. Clinical Phase Costs
    • 7.1.2. Capitalized Costs
  • 7.2. Proportion of Manufacturing Cost Structure
    • 7.2.1. Raw Materials
    • 7.2.2. Labor Cost
    • 7.2.3. Manufacturing Expenses
    • 7.2.4. Other Costs Analysis
  • 7.3. Manufacturing Process Analysis of Pruritus Therapeutics

8. Industrial Chain, Sourcing Strategy and Downstream Buyers

  • 8.1. Pruritus Therapeutics Industrial Chain Analysis
  • 8.2. Upstream Raw Materials Sourcing
  • 8.3. Downstream Buyers

9. Marketing Strategy Analysis, Distributors/Traders

  • 9.1. Marketing Channel
    • 9.1.1. Direct Marketing
    • 9.1.2. Indirect Marketing
    • 9.1.3. Marketing Channel Development Trend
  • 9.2. Market Positioning
    • 9.2.1. Pricing Strategy
    • 9.2.2. Brand Strategy
  • 9.3. Distributors/Traders List

10. Market Effect Factors Analysis

  • 10.1. Market Drivers
  • 10.2. Consumer Needs/Customer Preference Change
  • 10.3. Economic/Political Environmental Change

11. Global Pruritus Therapeutics Market Forecast (2017-2022)

  • 11.1. Global Pruritus Therapeutics Revenue Forecast (2017-2022)
  • 11.2. Global Pruritus Therapeutics Revenue Forecast by Regions (2017-2022)
    • 11.2.1. North America Pruritus Therapeutics Revenue Forecast (2017-2022)
    • 11.2.2. Europe Pruritus Therapeutics and Revenue Forecast (2017-2022)
    • 11.2.3. Asia-Pacific Pruritus Therapeutics Revenue Forecast (2017-2022)
    • 11.2.4. South America Pruritus Therapeutics Revenue Forecast (2017-2022)
    • 11.2.5. Middle East and Africa Pruritus Therapeutics Revenue Forecast (2017-2022)
  • 11.3. Global Pruritus Therapeutics Revenue Forecast by Type (2017-2022)
  • 11.4. Global Pruritus Therapeutics Revenue Forecast by Application (2017-2022)

12. Research Findings and Conclusion

13. Methodology and Data Source

  • 13.1. Methodology/Research Approach
    • 13.1.1. Research Programs/Design
    • 13.1.2. Market Size Estimation
    • 13.1.3. Market Breakdown and Data Triangulation
  • 13.2. Data Source
    • 13.2.1. Secondary Sources
    • 13.2.2. Primary Sources
  • 13.3. Disclaimer
  • 13.4. Author List

List of Tables and Figures

  • Figure Picture of Pruritus Therapeutics
  • Table Global Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Comparison by Types (Product Category) (2012-2022)
  • Figure Global Revenue Market Share of Pruritus Therapeutics by Types in 2016
  • Figure Product Picture of Corticosteroids
  • Figure Product Picture of Antihistamines
  • Figure Product Picture of Calcineurin Inhibitors
  • Table Global Pruritus Therapeutics Revenue (M USD) Comparison by Applications (2012-2022)
  • Figure Pruritus Therapeutics Revenue Market Share by Applications in 2016
  • Figure External Use Examples
  • Figure Oral Examples
  • Figure Injection Examples
  • Table Global Market Pruritus Therapeutics Revenue (M USD) Comparison by Regions 2012-2022
  • Figure North America Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)
  • Figure Asia-Pacific Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)
  • Figure Europe Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)
  • Figure South America Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)
  • Figure Middle East and Africa Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)
  • Figure Global Pruritus Therapeutics Revenue (M USD) and Growth Rate (2012-2022)
  • Table Global Pruritus Therapeutics Revenue (M USD) by Manufacturers (2016 and 2017)
  • Table Global Pruritus Therapeutics Revenue Share by Manufacturers (2016 and 2017)
  • Figure 2016 Global Pruritus Therapeutics Revenue Share by Manufacturers
  • Figure 2017 Global Pruritus Therapeutics Revenue Share by Manufacturers
  • Table Global Pruritus Therapeutics Gross Profit (M USD) of Key Manufacturers (2016 and 2017)
  • Table Global Pruritus Therapeutics Gross Profit Share by Manufacturers (2016 and 2017)
  • Figure 2016 Pruritus Therapeutics Gross Profit Share by Manufacturers
  • Figure 2017 Pruritus Therapeutics Gross Profit Share by Manufacturers
  • Table Global Market Pruritus Therapeutics Gross Margin of Key Manufacturers (2016 and 2017)
  • Figure Global Market Pruritus Therapeutics Gross Margin of Key Manufacturers in 2016
  • Figure Global Market Pruritus Therapeutics Gross Margin of Key Manufacturers in 2017
  • Table Manufacturers Pruritus Therapeutics Headquarters and Founded Time
  • Figure Pruritus Therapeutics Revenue Market Concentration Rate in 2016
  • Figure Pruritus Therapeutics Revenue Market Share of Top 3 Manufacturers in 2016
  • Figure Pruritus Therapeutics Revenue Market Share of Top 5 Manufacturers in 2016
  • Table Mergers & Acquisitions, Expansion
  • Table Global Pruritus Therapeutics Revenue (M USD) by Regions (2012-2017)
  • Table Global Pruritus Therapeutics Revenue Market Share by Regions (2012-2017)
  • Figure 2012-2017 Global Pruritus Therapeutics Revenue Market Share by Regions
  • Table 2016 Global Pruritus Therapeutics Revenue Market Share by Regions
  • Table Global Pruritus Therapeutics Gross Profit (M USD) by Regions (2012-2017)
  • Figure Global Pruritus Therapeutics Gross Profit and Market Share by Regions (2012-2017)
  • Figure 2012-2017 Global Pruritus Therapeutics Gross Profit Market Share by Regions
  • Table 2016 Global Pruritus Therapeutics Gross Profit Market Share by Regions
  • Table Global Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)
  • Table North America Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)
  • Table Europe Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)
  • Table Asia-Pacific Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)
  • Table South America Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)
  • Table Middle East and Africa Pruritus Therapeutics Revenue (M USD) and Gross Margin (2012-2017)
  • Table Global Pruritus Therapeutics Revenue (M USD) by Product Catalog (2012-2017)
  • Table Global Pruritus Therapeutics Revenue Share (%) by Product Catalog (2012-2017)
  • Figure Revenue Market Share (%) of Pruritus Therapeutics by Product Catalog (2012-2017)
  • Figure 2016 Revenue Market Share (%) of Pruritus Therapeutics by Product Catalog
  • Figure Global Pruritus Therapeutics Revenue Growth (%) by Type (2012-2017)
  • Table Global Pruritus Therapeutics Revenue (M USD) by Applications (2012-2017)
  • Table Global Pruritus Therapeutics Revenue Market Share (%) by Applications (2012-2017)
  • Figure Global Pruritus Therapeutics Revenue Market Share (%) by Applications (2012-2017)
  • Figure Global Pruritus Therapeutics Revenue Market Share (%) by Applications in 2016
  • Table Global Pruritus Therapeutics Revenue Growth Rate (%) by Applications (2012-2017)
  • Figure Global Pruritus Therapeutics Revenue Growth Rate (%) by Applications (2012-2017)
  • Table J&J Company Profile
  • Figure Pruritus Therapeutics Product Introduction of J&J
  • Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of J&J 2016-2017
  • Table Abbott Company Profile
  • Figure Pruritus Therapeutics Product Introduction of Abbott
  • Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Abbott 2016-2017
  • Table Amgen Company Profile
  • Figure Pruritus Therapeutics Product Introduction of Amgen
  • Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Amgen 2016-2017
  • Table LEO Pharma Company Profile
  • Figure Pruritus Therapeutics Product Introduction of LEO Pharma
  • Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of LEO Pharma 2016-2017
  • Table Novartis Company Profile
  • Figure Pruritus Therapeutics Product Introduction of Novartis
  • Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Novartis 2016-2017
  • Table Bayer Company Profile
  • Figure Pruritus Therapeutics Product Introduction of Bayer
  • Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Bayer 2016-2017
  • Table Pfizer Company Profile
  • Figure Pruritus Therapeutics Product Introduction of Pfizer
  • Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Pfizer 2016-2017
  • Table UCB Pharma Company Profile
  • Figure Pruritus Therapeutics Product Introduction of UCB Pharma
  • Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of UCB Pharma 2016-2017
  • Table GlaxoSmithKline Company Profile
  • Figure Pruritus Therapeutics Product Introduction of GlaxoSmithKline
  • Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of GlaxoSmithKline 2016-2017
  • Table Galderma Company Profile
  • Figure Pruritus Therapeutics Product Introduction of Galderma
  • Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Galderma 2016-2017
  • Table Huapont Company Profile
  • Figure Pruritus Therapeutics Product Introduction of Huapont
  • Table Pruritus Therapeutics Revenue (M USD), Cost (M USD), Gross Profit (M USD) and Gross Margin of Huapont 2016-2017
  • Figure Typical Phases from Research to the Market for a Drug Candidate
  • Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Pruritus Therapeutics Compound
  • Table Capitalized Preclinical and Clinical Period Costs per Investigational Pruritus Therapeutics Compound
  • Table Manufacturing Cost Structure of Pruritus Therapeutics
  • Figure Brazil Overview of Average Monthly Wages 2015-2016 (BRL/Month)
  • Figure Argentina Overview of Average Monthly Wages 2012-2016 (ARS/Month)
  • Figure Mexico Overview of Average Monthly Wages 2012-2016(MXN/Day)
  • Figure USA Labor Cost Analysis
  • Figure Cost of Employing a Factory Worker
  • Figure 2016 Estimated Labour Costs for the Whole Economy in EuropeR
  • Figure Monthly Minimum Wages in Asia 2016
  • Figure China Labor Costs
  • Table Average Price of Electricity to Ultimate Customers
  • Figure Electricity Prices for Household Consumers in 2016
  • Figure Summary of the Driving Assumptions
  • Figure Industrial Electric Rates 2016 (PER KWH)
  • Figure Manufacturing Process Analysis of Pruritus Therapeutics
  • Figure Pruritus Therapeutics Industrial Chain Analysis
  • Table Major Buyers of Pruritus Therapeutics
  • Figure Marketing Channel for Pruritus Therapeutics
  • Table Distributors/Traders List
  • Table Market Drivers of Pruritus Therapeutics
  • Figure Global GDP Growth Rate for 2015
  • Figure US GDP 2006-2016 (Billion USD)
  • Figure US CPI Change 2016-2017
  • Figure EU GDP 2006-2016 (Billion USD)
  • Figure EU CPI Change 2012-2016
  • Figure Germany GDP 2006-2016 (Billion USD)
  • Figure Germany CPI Change 2016-2017
  • Figure UK GDP 2006-2016 (Billion USD)
  • Figure UK CPI Change 2016-2017
  • Figure Italy GDP 2006-2016 (Billion USD)
  • Figure Italy CPI Change 2016-2017
  • Figure Japan GDP 2006-2016 (Billion USD)
  • Figure Japan CPI Change 2012-2016
  • Figure China GDP 2006-2016 (Billion USD)
  • Figure China CPI Change 2016-2017
  • Figure Global Pruritus Therapeutics Revenue (M USD) and Growth Rate Forecast (2017-2022)
  • Table Global Pruritus Therapeutics Revenue (M USD) Forecast by Regions (2017-2022)
  • Figure Global Pruritus Therapeutics Revenue Forecast by Regions (2017-2022)
  • Figure North America Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
  • Figure Europe Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
  • Figure Asia-Pacific Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
  • Figure South America Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
  • Figure Middle East and Africa Pruritus Therapeutics Revenue (M USD) and Growth Rate (%) Forecast (2017-2022)
  • Table Global Pruritus Therapeutics Revenue (M USD) Forecast by Product Catalog (2017-2022)
  • Figure Global Pruritus Therapeutics Revenue Market Share (%) Forecast by Product Catalog (2017-2022)
  • Table Global Pruritus Therapeutics Revenue (M USD) Forecast by Application (2017-2022)
  • Figure Global Pruritus Therapeutics Revenue Forecast by Application (2017-2022)
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
Back to Top